Namibia - English - Namibia Medicines Regulatory Council

glenmark pharmaceuticals south africa (pty) ltd - fluocinolone acetonide, clioquinol - ointment - each 1g ointment contains fluocinolone acetonide 0.25 mg , clioquinol 30 mg

Namibia - English - Namibia Medicines Regulatory Council

msd pty ltd - betamethasone valerate, tolnaftate , gentamicin sulphate, clioquinol - cream - each gram cream contains : betamethasone valerate 0,5 mg, tolnaftate 10,0 mg, gentamicin sulphate 1,0 mg, clioquinol 10 mg

Philippines - English - FDA (Food And Drug Administration)

vendiz pharmaceuticals inc.; importer: n/a; distributor: n/a - tolnaftate/ clioquinol/ gentamicin (as sulfate)/betamethasone (as valerate) - cream - 10 mg/ 10 mg/ 1 mg/ 500 mcg per g

United States - English - NLM (National Library of Medicine)

crown laboratories - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone 5 mg in 1 g

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

lincoln pharmaceuticals limited, india - betamethasone 0.61 mg , gentamicin 1.0 mg ,tolnaftate 10.0 mg ,clioquinol 10.0 mg - cream - 10 mg/g + 10 mg/g + 0.61 mg/g + 1 mg/g

United States - English - NLM (National Library of Medicine)

crown laboratories - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj), clioquinol (unii: 7bhq856ej5) (clioquinol - unii:7bhq856ej5) - hydrocortisone 5 mg in 1 g - based on a review of this drug by the national academy of sciences-national research council and/or other information, fda has classified the indications as follows: “possibly” effective: contact or atopic dermatitis; impetiginized eczema; nummular eczema; infantile eczema; endogenous chronic infectious dermatitis; stasis dermatitis; pyoderma; nuchal eczema and chronic eczematoid otitis externa; acne urticata; localized or disseminated neurodermatitis; lichen simplex chronicus; anogenital pruritus (vulvae, scroti, ani); folliculitis; bacterial dermatoses; mycotic dermatoses such as tinea (capitis, cruris, corporis, pedis); moniliasis; intertrigo. final classification of the less-than-effective indications requires further investigation. hypersensitivity to lodochlorhydroxyquin-hydrocortisone, or any of its ingredients or related compounds: lesions of the eye, tuberculosis of the skin; most viral skin lesions (including herpes simplex, vaccinia, and varicella). patients sensitive to chloroxine, iodine, or iodi

Singapore - English - HSA (Health Sciences Authority)

icm pharma pte. ltd. - betamethasone valerate eqv betamethasone; clioquinol - cream - 0.025% w/w - betamethasone valerate eqv betamethasone 0.025% w/w; clioquinol 3% w/w

Singapore - English - HSA (Health Sciences Authority)

icm pharma pte. ltd. - betamethasone valerate eqv betamethasone; clioquinol - cream - 0.05% w/w - betamethasone valerate eqv betamethasone 0.05% w/w; clioquinol 3% w/w

Singapore - English - HSA (Health Sciences Authority)

icm pharma pte. ltd. - betamethasone valerate eqv betamethasone; clioquinol - cream - 0.1% w/w - betamethasone valerate eqv betamethasone 0.1% w/w; clioquinol 3% w/w

Philippines - English - FDA (Food And Drug Administration)

lloyd labs inc - betamethasone (as valerate) , gentamicin (as sulfate) , tolnaftate , clioquinol - ointment, topical - 500mcg+1mg+10mg+10mg/g